In order to elucidate the influencing factors of Th17 cells enhancement in DM patients, we analyzed the levels of IL-6, IL-1, TGF-β, and IL-23 in serum from DM patients and healthy controls. The gene discussed is IL6; the disease is dermatomyositis.